Counterpoint Quantitative Equity ETF (NYSE:CPAI – Get Free Report) was the recipient of a large decrease in short interest in September. As of September 15th, there was short interest totaling 14,099 shares, a decrease of 75.0% from the August 31st total of 56,323 shares. Based on an average trading volume of 57,065 shares, the short-interest ratio is presently 0.2 days. Approximately 0.1% of the company’s stock are sold short.
Counterpoint Quantitative Equity ETF Stock Performance
Shares of CPAI traded up $0.21 on Friday, reaching $52.36. The stock had a trading volume of 178,743 shares, compared to its average volume of 57,228. Counterpoint Quantitative Equity ETF has a 12-month low of $37.29 and a 12-month high of $53.96. The firm has a market capitalization of $466.00 million, a price-to-earnings ratio of -62,780.58 and a beta of 1.19. The company has a 50-day simple moving average of $51.73 and a 200-day simple moving average of $48.82.
Hedge Funds Weigh In On Counterpoint Quantitative Equity ETF
Several institutional investors and hedge funds have recently added to or reduced their stakes in CPAI. IFP Advisors Inc boosted its holdings in shares of Counterpoint Quantitative Equity ETF by 228.3% during the 4th quarter. IFP Advisors Inc now owns 906 shares of the company’s stock valued at $36,000 after buying an additional 630 shares in the last quarter. Western Wealth Management LLC purchased a new position in Counterpoint Quantitative Equity ETF during the 1st quarter valued at about $57,000. Fifth Third Bancorp purchased a new position in Counterpoint Quantitative Equity ETF during the 1st quarter valued at about $72,000. PUREfi Wealth LLC purchased a new position in Counterpoint Quantitative Equity ETF during the 1st quarter valued at about $209,000. Finally, Concurrent Investment Advisors LLC boosted its stake in Counterpoint Quantitative Equity ETF by 8.2% during the second quarter. Concurrent Investment Advisors LLC now owns 100,854 shares of the company’s stock worth $5,240,000 after acquiring an additional 7,641 shares in the last quarter.
About Counterpoint Quantitative Equity ETF
The Counterpoint Quantitative Equity ETF (CPAI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through a quantitative, model-based approach to select US stocks of any market capitalization. CPAI was launched on Nov 28, 2023 and is issued by Counterpoint.
See Also
- Five stocks we like better than Counterpoint Quantitative Equity ETF
- Data Centers Got the AI Hype—But Office REITs May Get the Rent Hikes
- 2 Cybersecurity Stocks Breaking Out as AI Continues to Be a Tailwind
- 3 More AI Infrastructure Plays Beyond the Big Names
- CAVA Stock Slips: Sector Fear or Valuation Reality?
Receive News & Ratings for Counterpoint Quantitative Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Counterpoint Quantitative Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
